[ Price : $8.95]
Dizal Pharmaceutical submits an NDA for sunvozertinib for treating locally advanced or metastatic non-small cell lung cancer.[ Price : $8.95]
FDA extends its review of a Neurotech Pharmaceuticals BLA for NT-501 (revakinagene taroretcel) as a treatment for macular telangie...[ Price : $8.95]
Public Citizen preemptively criticizes expected 2025 legislation to authorize FDA to approve drugs for rare diseases based on subs...[ Price : $8.95]
Federal Register notice: FDA issues a proposed administrative order to remove orally administered phenylephrine in OTC nasal decon...[ Price : $8.95]
FDA cites a lack of adequate training in FY 2023 Good Laboratory Practice inspection form FDA-483s.[ Price : $8.95]
FDA approves the J&J Varipulse pulsed field ablation platform to treat atrial fibrillation.[ Price : $8.95]
Based on safety concerns, Sarepta says it is discontinuing the development of SRP-5051 (vesleteplirsen) for treating patients with...[ Price : $8.95]
Four stakeholders respond to an FDA request for comments on guidance development and engaging with stakeholders on model-informed ...